🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A new #NIAID study, published in Science, shows strong responses from immune cells called CD8+ T cells may play a key role in an effective #HIV #vaccine. This study could guide development of future HIV vaccines and immunotherapy approaches. Read more: go.nih.gov/kTVpcAp

Mechanistic study showing why an adenovirus-based HIV vaccine failed to provide protection. Honored to have contributed to this work as a ⁦NIH⁩ postbac IRTA, a happy ending to a long scientific odyssey. science.org/doi/10.1126/sc…

Over the moon to share that this has now been published in nature! Congrats to everyone involved! Check it out here - rdcu.be/dt907 Or watch us chat about it here - youtu.be/gOMMK49rhmg

Matched to my #1 residency program, Cornell’s physician scientist track! Thank you to my family, friends, mentors, and organizations like PD Soros Fellowships NIHOxCam UCSD MSTP who supported me along this long road.

Congratulations to all the 2024 #PDsoros fellows, welcome to the family and can’t wait to meet you!

Second-generation mosquito nets prevented 13 million malaria cases and 25,000 deaths in large pilot programs. trib.al/3rGaXPw

Phase II trial where monoclonal antibody L9LS protected 60-70% of children in Mali against malaria for 6mo! Dream come true to see something I pipetted translate into protecting at-risk kids. Can’t wait for the phase III data! #WorldMalariaDay2024 nejm.org/doi/full/10.10…

Our paper "Integrating population and single-cell variations in vaccine responses identifies a naturally adjuvanted human immune setpoint" John Tsang @tsanglab.bsky.social is now online Immunity Link to open access pdf: authors.elsevier.com/c/1j0dm3qNrUxt…

Doctors Without Borders challenges pharma by releasing costs for a key clinical trial. trib.al/AFkvx65

Congrats to all for the huge collaborative effort, especially co-authors Lawrence T Wang and Andrew Cooper, and my excellent summer student Maciej Maciuszek for helping me with some of the many crystal trays. And a big thanks to Josh and Matt Higgins for inviting me on board. 2/n

Very pleased to share our comprehensive review on monoclonal antibodies against circumsporozoite protein and how this emerging tool might aid global efforts to control malaria, published today in Nature Immunology! Azza Idris, MD, PhD, we did it! :) nature.com/articles/s4159…

The new issue is out 👉cell.com/cell/current Featuring allogeneic CD19-targeted CAR-T therapy for severe refractory autoimmune diseases, and an in-depth analysis of antibody responses induced by malaria infection and vaccine candidate RH5.⁠ ⁠ The cover image shows a

In the latest issue! Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5 dlvr.it/TCxsfN

In the latest issue! Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype dlvr.it/TCyG6N

Delighted that we have been selected as the cover story(ies) for the current issue of Cell! Thanks to Cell for selecting us and to everyone for your hard work on this, especially co-authors Lawrence T Wang and Brendan Farrell. cell.com/cell/issue?pii… 1/12

Breakthrough in malaria research! 🚨 The RH5.1/Matrix-M™ vaccine shows 55% efficacy against blood-stage malaria in children and >80% against high parasite levels. Safe, well-tolerated, and a key step forward. 🔗kavli.web.ox.ac.uk/article/trial-… Medical Sciences University of Oxford The Kavli Foundation